The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Golden Eye 0.1% w/v Eye drops, solution

Cambridge Healthcare Ireland LimitedPA22695/001/001

Main Information

Trade NameGolden Eye 0.1% w/v Eye drops, solution
Active SubstancesPropamidine isetionate
Dosage FormEye drops, solution
Licence HolderCambridge Healthcare Ireland Limited
Licence NumberPA22695/001/001

Group Information

ATC CodeS01AX Other antiinfectives
S01AX15 propamidine


License statusAuthorised
Licence Issued02/03/1993
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence1. Do not use 4 weeks after first opening. 2. If symptoms persist for more than two days, discontinue use and consult your doctor. 3. Do not use when wearing contact lenses.
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back